The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF

Biomaterials

Volumn 30, Issue 27, 2009, Pages 4618-4628

  Anderson, Sean M ^a   Chen, Tom T ^a   Iruela Arispe, M Luisa ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Cell signaling; Endothelial cell; Fibronectin; Growth factors; Heparin

Indexed keywords

ANGIOGENESIS; CELL SIGNALING; FIBRONECTIN; GROWTH FACTORS; HEPARIN;

BIOACTIVITY; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; ENDOTHELIAL CELLS; FUNCTIONAL GROUPS; PEPTIDES; POLYSACCHARIDES; SELF ASSEMBLY; SIGNALING; SURFACE PLASMON RESONANCE; SURFACES;

CYTOLOGY;

HEPARIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN IMMOBILIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; UMBILICAL VEIN;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOLD; HEPARIN; HUMANS; IMMOBILIZED PROTEINS; MICROSCOPY, FLUORESCENCE; OXIDATION-REDUCTION; PHOSPHORYLATION; SPECTROPHOTOMETRY, INFRARED; STATIC ELECTRICITY; SURFACE PLASMON RESONANCE; SURFACE PROPERTIES; SUS SCROFA; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 67651165008     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.05.030     Document Type: Article

References (40)

1. Ehrbar M., Zeisberger S.M., Raeber G.P., Hubbell J.A., Schnell C., and Zisch A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 29 11 (2008) 1720-1729
2. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., McCombe D., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115 3 (2007) 353-360
3. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7 5 (2006) 359-371
4. Fairbrother W.J., Champe M.A., Christinger H.W., Keyt B.A., and Starovasnik M.A. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6 5 (1998) 637-648
5. Catena R., Muniz-Medina V., Moralejo B., Javierre B., Best C.J., Emmert-Buck M.R., et al. Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis. Int J Cancer 120 10 (2007) 2096-2109
6. Hawinkels L.J., Zuidwijk K., Verspaget H.W., de Jonge-Muller E.S., van Duijn W., Ferreira V., et al. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44 13 (2008) 1904-1913
7. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17 15 (2003) 2260-2262
8. Lee S., Jilani S.M., Nikolova G.V., Carpizo D., and Iruela-Arispe M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169 4 (2005) 681-691
9. Shen Y.H., Shoichet M.S., and Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 4 3 (2008) 477-489
10. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72 1-3 (2001) 101-113
11. Backer M.V., Patel V., Jehning B.T., Claffey K.P., and Backer J.M. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials 27 31 (2006) 5452-5458
12. Zhang Y., Furumura M., and Morita E. Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165. Growth Factors 26 3 (2008) 125-131
13. Yu L.M., Wosnick J.H., and Shoichet M.S. Miniaturized system of neurotrophin patterning for guided regeneration. J Neurosci Methods 171 2 (2008) 253-263
14. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 25 5 (2007) 1241-1251
15. Leclerc C., Brose C., Nouze C., Leonard F., Majlessi L., Becker S., et al. Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines. J Biomed Mater Res A 86 4 (2008) 1033-1040
16. Mann B.K., Schmedlen R.H., and West J.L. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22 5 (2001) 439-444
17. Stefonek-Puccinelli T.J., and Masters K.S. Co-immobilization of gradient-patterned growth factors for directed cell migration. Ann Biomed Eng 36 12 (2008) 2121-2133
18. Park T.J., Lee S.Y., Lee S.J., Park J.P., Yang K.S., Lee K.B., et al. Protein nanopatterns and biosensors using gold binding polypeptide as a fusion partner. Anal Chem 78 20 (2006) 7197-7205
19. Gunawan R.C., King J.A., Lee B.P., Messersmith P.B., and Miller W.M. Surface presentation of bioactive ligands in a nonadhesive background using DOPA-tethered biotinylated poly(ethylene glycol). Langmuir 23 21 (2007) 10635-10643
20. Hodneland C.D., Lee Y.S., Min D.H., and Mrksich M. Selective immobilization of proteins to self-assembled monolayers presenting active site-directed capture ligands. Proc Natl Acad Sci U S A 99 8 (2002) 5048-5052
21. Backer M.V., Patel V., Jehning B.T., and Backer J.M. Self-assembled "dock and lock" system for linking payloads to targeting proteins. Bioconjug Chem 17 4 (2006) 912-919
22. Steffens G.C., Yao C., Prevel P., Markowicz M., Schenck P., Noah E.M., et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 10 9-10 (2004) 1502-1509
23. Schroeder-Tefft J.A., Bentz H., and Estridge T.D. Collagen and heparin matrices for growth factor delivery. J Control Release 49 2-3 (1997) 291-298
24. Lee M., Chen T.T., Iruela-Arispe M.L., Wu B.M., and Dunn J.C. Modulation of protein delivery from modular polymer scaffolds. Biomaterials 28 10 (2007) 1862-1870
25. Yamaguchi N., and Kiick K.L. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 6 4 (2005) 1921-1930
26. Benoit D.S., and Anseth K.S. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 1 4 (2005) 461-470
27. Christman K.L., Vazquez-Dorbatt V., Schopf E., Kolodziej C.M., Li R.C., Broyer R.M., et al. Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer. J Am Chem Soc (2008)
28. Ichinose J., Morimatsu M., Yanagida T., and Sako Y. Covalent immobilization of epidermal growth factor molecules for single-molecule imaging analysis of intracellular signaling. Biomaterials 27 18 (2006) 3343-3350
29. Tidwell C.D., Ertel S.I., Ratner B.D., Tarasevich B.J., Atre S., and Allara D.L. Endothelial cell growth and protein adsorption on terminally functionalized, self-assembled monolayers of alkanethiolates on gold. Langmuir 13 13 (1997) 3404-3413
30. Prime K.L., and Whitesides G.M. Adsorption of proteins onto surfaces containing end-attached oligo(ethylene oxide): a model system using self-assembled monolayers. J Am Chem Soc 115 23 (1993) 10714-10721
31. Petrie T.A., Capadona J.R., Reyes C.D., and Garcia A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 27 31 (2006) 5459-5470
32. Mitsi M., Hong Z., Costello C.E., and Nugent M.A. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45 34 (2006) 10319-10328
33. Wijelath E.S., Rahman S., Namekata M., Murray J., Nishimura T., Mostafavi-Pour Z., et al. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 99 8 (2006) 853-860
34. Ricard-Blum S., Beraud M., Raynal N., Farndale R.W., and Ruggiero F. Structural requirements for heparin/heparan sulfate binding to type V collagen. J Biol Chem 281 35 (2006) 25195-25204
35. Maile L.A., Busby W.H., Sitko K., Capps B.E., Sergent T., Badley-Clarke J., et al. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol 20 4 (2006) 881-892
36. Yamashita H., Beck K., and Kitagawa Y. Heparin binds to the laminin alpha4 chain LG4 domain at a site different from that found for other laminins. J Mol Biol 335 5 (2004) 1145-1149
37. Wijelath E.S., Murray J., Rahman S., Patel Y., Ishida A., Strand K., et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Am Heart Assoc (2002) 25-31
38. Ostuni E., Chapman R.G., Liang M.N., Meluleni G., Pier G., Ingber D.E., et al. Self-assembled monolayers that resist the adsorption of proteins and the adhesion of bacterial and mammalian cells. Langmuir 17 20 (2001) 6336-6343
39. Huang J., and Hemminger J.C. Photooxidation of thiols in self-assembled monolayers on gold. J Am Chem Soc 115 8 (1993) 3342-3343
40. Gong N., and Chatterjee S. Platelet endothelial cell adhesion molecule in cell signaling and thrombosis. Mol Cell Biochem 253 1-2 (2003) 151-158